A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.
Ventures that aim to advance medical technology stand and fall by the science they are based on. Any action taken must be supported by adequate evidence and the evaluation of such evidence allows us to distinguish our investments.
This publication showcases how accurate evaluation of available evidence allows for a more productive approaches in the understanding and treatment of diseases.
More to follow
Please check back later for new publications.